Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00008177
Status:
COMPLETED
Last Update Posted:
2019-11-13
First Post:
2001-01-06
Brief Title:
Radiolabeled Monoclonal Antibody Therapy Fludarabine Phosphate and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Untreated Adult Acute Myeloid Leukemia |
| Adult Acute Myeloid Leukemia in Remission |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Del5q |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Chronic Myelomonocytic Leukemia |
| de Novo Myelodysplastic Syndromes |
| Previously Treated Myelodysplastic Syndromes |
| Recurrent Adult Acute Myeloid Leukemia |
| Refractory Anemia With Excess Blasts |
| Refractory Anemia With Excess Blasts in Transformation |
| Refractory Anemia With Ringed Sideroblasts |
| Refractory Cytopenia With Multilineage Dysplasia |
| Secondary Myelodysplastic Syndromes |
Keywords: